| Immunotherapy augments the effect of 5-azacytidine on HPV16-associated tumours with different MHC class I-expression status. | |
| | |
MedLine Citation:
|
PMID: 22015556 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Epigenetic mechanisms have important roles in the tumour escape from immune responses, such as in MHC class I downregulation or altered expression of other components involved in antigen presentation. Chemotherapy with DNA methyltransferase inhibitors (DNMTi) can thus influence the tumour cell interactions with the immune system and their sensitivity to immunotherapy. METHODS: We evaluated the therapeutic effects of the DNMTi 5-azacytidine (5AC) against experimental MHC class I-deficient and -positive tumours. The 5AC therapy was combined with immunotherapy, using a murine model for HPV16-associated tumours. RESULTS: We have demonstrated 5AC additive effects against MHC class I-positive and -deficient tumours when combined with unmethylated CpG oligodeoxynucleotides or with IL-12-producing cellular vaccine. The efficacy of the combined chemoimmunotherapy against originally MHC class I-deficient tumours was partially dependent on the CD8(+)-mediated immune responses. Increased cell surface expression of MHC class I cell molecules, associated with upregulation of the antigen-presenting machinery-related genes, as well as of genes encoding selected components of the IFNγ-signalling pathway in tumours explanted from 5AC-treated animals, were observed. CONCLUSION: Our data suggest that chemotherapy of MHC class I-deficient tumours with 5AC combined with immunotherapy is an attractive setting in the treatment of MHC class I-deficient tumours. |
| | |
Authors:
|
J Símová; V Polláková; M Indrová; R Mikyšková; J Bieblová; I Stěpánek; J Bubeník; M Reiniš |
Related Documents
:
|
10563496 - Absence of fas (cd95) and fasl (cd95l) immunohistochemical expression suggests fas/fasl... 18324486 - Identification of apoptotic proteins in thyroid gland from patients with graves' diseas... 12674766 - Effects of shenmai and aminophylline on apoptosis of small airway smooth muscle cells a... 15809706 - Augmentation of fas ligand-induced apoptosis by muc1 mucin. 1693296 - Further studies on growth factor production by the tc-1 stromal cell line: pre-b stimul... 16516156 - Beta cell cytoprotective strategies: establishing the relative roles for inos and ros. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2011-10-20 |
Journal Detail:
|
Title: British journal of cancer Volume: 105 ISSN: 1532-1827 ISO Abbreviation: Br. J. Cancer Publication Date: 2011 Nov |
Date Detail:
|
Created Date: 2011-11-09 Completed Date: 2011-12-20 Revised Date: 2011-12-23 |
Medline Journal Info:
|
Nlm Unique ID: 0370635 Medline TA: Br J Cancer Country: England |
Other Details:
|
Languages: eng Pagination: 1533-41 Citation Subset: IM |
Copyright Information:
|
2011 Cancer Research UK |
Affiliation:
|
Department of Tumour Immunology, Institute of Molecular Genetics, v.v.i., Academy of Sciences of the Czech Republic, Videnska 1083, Prague 4 14220, Czech Republic. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Antimetabolites, Antineoplastic / pharmacology* Azacitidine / pharmacology* Base Sequence DNA Primers Enzyme-Linked Immunosorbent Assay Histocompatibility Antigens Class I / immunology* Human papillomavirus 16 / isolation & purification* Immunotherapy* Male Methylation Mice Mice, Inbred C57BL Neoplasms, Experimental / drug therapy, immunology, therapy*, virology Real-Time Polymerase Chain Reaction |
| Chemical | |
Reg. No./Substance:
|
0/Antimetabolites, Antineoplastic; 0/DNA Primers; 0/Histocompatibility Antigens Class I; 320-67-2/Azacitidine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Host-derived MMP-13 exhibits a protective role in lung metastasis of melanoma cells by local endosta...
Next Document: Targeting PIM kinase enhances the activity of sunitinib in renal cell carcinoma.